DK1075477T3 - Nye benzonaphthyridin-N-oxider - Google Patents

Nye benzonaphthyridin-N-oxider

Info

Publication number
DK1075477T3
DK1075477T3 DK99922133T DK99922133T DK1075477T3 DK 1075477 T3 DK1075477 T3 DK 1075477T3 DK 99922133 T DK99922133 T DK 99922133T DK 99922133 T DK99922133 T DK 99922133T DK 1075477 T3 DK1075477 T3 DK 1075477T3
Authority
DK
Denmark
Prior art keywords
oxides
benzonaphthyridine
new
hand
pde3
Prior art date
Application number
DK99922133T
Other languages
Danish (da)
English (en)
Inventor
Hermann Amschler
Wolf-Ruediger Ulrich
Thomas Baer
Armin Hatzelmann
Rolf Beume
Daniela Bundschuh
Hans-Peter Kley
Dieter Flockerzi
Beate Gutterer
Thomas Martin
Hildegard Boss
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1075477T3 publication Critical patent/DK1075477T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
DK99922133T 1998-05-05 1999-04-27 Nye benzonaphthyridin-N-oxider DK1075477T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98108124 1998-05-05
PCT/EP1999/002827 WO1999057118A1 (de) 1998-05-05 1999-04-27 Neue n-oxide

Publications (1)

Publication Number Publication Date
DK1075477T3 true DK1075477T3 (da) 2003-06-30

Family

ID=8231880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99922133T DK1075477T3 (da) 1998-05-05 1999-04-27 Nye benzonaphthyridin-N-oxider

Country Status (12)

Country Link
US (1) US6306869B1 (enExample)
EP (1) EP1075477B1 (enExample)
JP (1) JP2002513793A (enExample)
AT (1) ATE234301T1 (enExample)
AU (1) AU3928999A (enExample)
CA (1) CA2330738A1 (enExample)
DE (1) DE59904535D1 (enExample)
DK (1) DK1075477T3 (enExample)
ES (1) ES2195571T3 (enExample)
PT (1) PT1075477E (enExample)
SI (1) SI1075477T1 (enExample)
WO (1) WO1999057118A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5970199A (en) 1998-08-31 2000-03-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
SI1212089T1 (sl) * 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
DE60133879D1 (de) 2000-01-11 2008-06-19 Nycomed Gmbh Phenanthridin -n- oxide
SI1377574T1 (enExample) * 2001-02-21 2005-08-31 Altana Pharma Ag
PL373598A1 (en) * 2002-08-17 2005-09-05 Altana Pharma Ag Novel benzonaphthyridines
AU2003255493B8 (en) * 2002-08-29 2009-03-26 Takeda Gmbh 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
JP4587295B2 (ja) * 2002-08-29 2010-11-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Pde4インヒビターとしての3−ヒドロキシ−6−フェニルフェナントリジン
DE60313331T2 (de) * 2002-09-04 2008-01-03 Nycomed Gmbh Neue benzonaphthyridine
US7470704B2 (en) 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
IS7839A (is) * 2002-11-22 2004-05-23 Merck Frosst Canada Ltd. 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
AU2005212857B2 (en) * 2004-02-18 2011-04-28 Takeda Gmbh Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
SI2589599T1 (sl) 2004-03-03 2014-10-30 Takeda Gmbh Novi hidroksi-6-heteroarilfenantridini in njihova uporaba kot PDE4 inhibitorji
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
WO2005084104A2 (en) * 2004-03-09 2005-09-15 Altana Pharma Ag Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
JP2007527900A (ja) * 2004-03-10 2007-10-04 アルタナ ファルマ アクチエンゲゼルシャフト チオ含有の新規のヒドロキシ−6−フェニルフェナントリジン及びpde4インヒビターとしてのそれらの使用
AU2005219581A1 (en) * 2004-03-10 2005-09-15 Nycomed Gmbh Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
AU2005221832A1 (en) * 2004-03-10 2005-09-22 Nycomed Gmbh Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
AU2005223386A1 (en) 2004-03-17 2005-09-29 Nycomed Gmbh Novel N- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE3/4 inhibitors
EP1791847A2 (en) 2004-09-08 2007-06-06 Altana Pharma AG Novel 3-thia-10-aza-phenanthrene derivatives
ES2365926T3 (es) * 2004-09-08 2011-10-13 Nycomed Gmbh 3-oxa-10-aza-fenantrenos como inhibidores de pde4 o pde3/4.
NZ560268A (en) 2005-03-02 2010-12-24 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
NZ334976A (en) 1996-11-11 2000-10-27 Byk Gulden Lomberg Chem Fab Benzonaphthyridine derivatives and their use for treating airway disorders and dermatoses

Also Published As

Publication number Publication date
PT1075477E (pt) 2003-07-31
JP2002513793A (ja) 2002-05-14
EP1075477A1 (de) 2001-02-14
AU3928999A (en) 1999-11-23
US6306869B1 (en) 2001-10-23
EP1075477B1 (de) 2003-03-12
CA2330738A1 (en) 1999-11-11
SI1075477T1 (en) 2003-08-31
ATE234301T1 (de) 2003-03-15
DE59904535D1 (de) 2003-04-17
WO1999057118A1 (de) 1999-11-11
ES2195571T3 (es) 2003-12-01

Similar Documents

Publication Publication Date Title
DK1075477T3 (da) Nye benzonaphthyridin-N-oxider
ATE233247T1 (de) Phtalazinonen
TR200400702T4 (tr) AMP özgü fosfodiesteraz inhibtörleri olarak 3-tiazol-4-il-pirolidin türevleri.
ATE466012T1 (de) Pyrazolo 3,4-b pyridinverbindungen und ihre verwendung als phosphodiesterase inhibitoren
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
PT1070056E (pt) Inibidores de pde iii/iv a base de ftalazinona
ATE234300T1 (de) Benzonaphthyridine als bronchialtherapeutika
ATE269331T1 (de) Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
NO20013341D0 (no) Fenylfenantridiner med PDE-IV inhiberende aktivitet
DE60007897D1 (de) 3-thiazol-4-yl-pyrrolidinderivate als amp-spezifische phosphodiesterase-inhibitoren
PT998460E (pt) Novos derivados de tetrazole
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
DE60318826D1 (de) Alkoxypyridinderivate
AR029214A1 (es) Compuestos inhibidores de fosfodiesterasa - 4: 8 - arilquinolinas sustituidas, composiciones farmaceuticas, metodo de tratamiento que las utiliza
PT1147103E (pt) Fenantridina-n-oxidos com actividade inibitoria de pde-iv
PT1147087E (pt) Feantridina-n-oxidos com actividade de inibicao de pde-iv
WO2002051848A3 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
DE60202669D1 (de) 6-phenylbenzonaphthyidine
ATE290002T1 (de) Cyclische amp spezifische phosphodiesterase inhibitoren
AU2001230180A1 (en) Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
ATE508130T1 (de) 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
PT1294729E (pt) 2-aminoalquil-tieno[2,3-d]pirimidinas
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
ATE338045T1 (de) Substituierte pyrido(1,2-a)pyrimidine und ihre verwendung als nos-inhibitoren